Table 1.
Clinical characteristics of the acromegaly patients and the controls.
| Male | Female | Age ≤ 40 | Age > 40 | ||
|---|---|---|---|---|---|
| Height, cm | Acromegaly patients | 172.99 ± 4.81∗∗ | 160.04 ± 6.45 | 166.84 ± 7.39 | 165.13 ± 9.50 |
| Controls | 165.37 ± 8.49 | 161.12 ± 5.70 | 162.04 ± 5.52 | 163.46 ± 8.30 | |
|
| |||||
| Weight, kg | Acromegaly patients | 79.81 ± 9.24 | 64.30 ± 7.81∗ | 69.51 ± 10.54 | 72.26 ± 12.09 |
| Controls | 74.35 ± 9.76 | 60.22 ± 9.90 | 62.58 ± 13.02 | 68.51 ± 10.75 | |
|
| |||||
| BMI | Acromegaly patients | 26.61 ± 2.23 | 25.13 ± 2.95∗∗ | 24.90 ± 2.63 | 26.35 ± 2.69 |
| Controls | 27.28 ± 3.71 | 23.15 ± 3.24 | 23.75 ± 4.27 | 25.64 ± 3.60 | |
|
| |||||
| Hypertension, n/% | Acromegaly patients | 3/18.75% | 6/30.00% | 0/0.00% | 9/40.91% |
| Controls | 1/6.67% | 2/9.09% | 0/0.00% | 3/14.29% | |
|
| |||||
| Diabetes mellitus, n/% | Acromegaly patients | 2/12.50% | 3/15.00% | 2/14.29% | 3/13.64% |
| Controls | 1/6.67% | 0/0.00% | 0/0.00% | 1/4.76% | |
|
| |||||
| Fasting GH, ng/ml | Acromegaly patients | 32.71 ± 45.08∗ | 14.54 ± 15.31∗∗ | 30.93 ± 48.12∗ | 17.32 ± 17.16∗∗ |
| Controls | 0.47 ± 0.49 | 0.47 ± 0.45 | 0.62 ± 0.48 | 0.36 ± 0.42 | |
|
| |||||
| IGF-1, ng/ml | Acromegaly patients | 1040.03 ± 179.60∗∗ | 785.35 ± 239.15∗∗ | 1007.29 ± 289.03∗∗ | 829.34 ± 248.12∗∗ |
| Controls | 179.60 ± 127.48 | 164.23 ± 92.72 | 194.00 ± 135.01 | 152.52 ± 77.82 | |
Comparisons were performed between the patients with acromegaly and the controls. ∗p < 0.05; ∗∗p < 0.01.